← Eichor
Study identifier: NCT06427447 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC)

Condition: Pancreatic Cancer  ·  Sponsor: Changhai Hospital

PhasePhase 3
Planned participants770
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

In this trial, we aim to compare the outcomes of adjuvant chemoradiotherapy with chemotherapy for patients with resected pancreatic cancer who are at high risk of disease progressions.

This description comes directly from the study's public registry record.

Talk to the study team

Xiaofei Zhu  ·  86-021-31162222  ·  zhuxiaofei_zxf@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Huojun ZhangShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06427447